Dataset Information


HOXA9 is required for survival in human MLL rearranged acute leukemias

ABSTRACT: Leukemias that harbor translocations involving the mixed lineage leukemia gene (MLL) possess unique biological characteristics and often have an unfavorable prognosis. Gene expression analyses demonstrate a distinct profile for MLL-rearranged leukemias with consistent high-level expression of select Homeobox genes including HOXA9. Here, we investigated the effects of HOXA9 suppression in MLL-rearranged and MLL-germline leukemias utilizing RNAi. Gene expression profiling after HOXA9 suppression demonstrated co-downregulation of a program highly expressed in human MLL-AML (this study) and murine MLL-leukemia (Krivtsov et al. 2006) stem cells including HOXA10, MEIS1, PBX3 and MEF2C. Our data indicates an important role for HOXA9 in human MLL-rearranged leukemias, and suggests targeting HOXA9 or downstream programs may be a novel therapeutic option. Overall design: RNA was purified from t(9;11) MOLM-14 AML cells 44h after transduction in triplicates with 2 of the two most effective HOXA9shRNA constructs (3 x 1F3-HOXA9shRNA; 3 x 2A5-HOXA9shRNA) or GFP-controlshRNA (6x).

INSTRUMENT(S): [HG-U133A_2] Affymetrix Human Genome U133A 2.0 Array

ORGANISM(S): Homo sapiens  

SUBMITTER: Joerg Faber 

PROVIDER: GSE13714 | GEO | 2009-01-01



Similar Datasets

2009-01-26 | E-GEOD-13714 | ArrayExpress
| GSE68643 | GEO
| GSE100820 | GEO
| GSE107078 | GEO
| GSE94240 | GEO
| GSE94241 | GEO
2013-01-09 | E-GEOD-43333 | ArrayExpress
2015-12-14 | E-GEOD-42990 | ArrayExpress
| GSE97450 | GEO
2009-11-23 | GSE18400 | GEO